Published in Hepatology on January 01, 1989
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut (2001) 4.12
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut (2003) 2.96
Hepatitis B: the virus and disease. Hepatology (2009) 2.48
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis. Am J Gastroenterol (2015) 1.78
Diagnosis of hepatocellular carcinoma. World J Gastroenterol (2009) 1.39
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review. Hepatol Int (2007) 1.13
Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics (2012) 1.10
'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease. Br J Cancer (1997) 1.08
Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. J Proteome Res (2009) 1.04
Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour. Br J Cancer (1999) 0.96
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis. J Hepatol (2012) 0.96
Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial. Br J Cancer (1989) 0.95
Hepatocellular carcinoma: Review of disease and tumor biomarkers. World J Hepatol (2016) 0.94
Recent developments in the first detection of hepatocellular carcinoma. Clin Biochem Rev (2005) 0.93
The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol (2009) 0.93
Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma. Korean J Intern Med (2005) 0.92
Leptomeningeal metastasis from hepatocellular carcinoma with other unusual metastases: a case report. BMC Cancer (2014) 0.88
Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels. Br J Cancer (1996) 0.88
Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma. World J Gastroenterol (2005) 0.87
Establishment and characterization of 7 novel hepatocellular carcinoma cell lines from patient-derived tumor xenografts. PLoS One (2014) 0.86
Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass. HPB (Oxford) (2013) 0.85
Structures of disease-specific serum alpha-fetoprotein isoforms. Br J Cancer (2000) 0.84
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol (2016) 0.83
Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma. World J Surg Oncol (2012) 0.83
Hepatitis B reactivation and rituximab in the oncology practice. Oncologist (2010) 0.80
Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma. PLoS One (2015) 0.78
Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma. World J Gastroenterol (2012) 0.78
Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol (2016) 0.77
Management strategies for hepatocellular carcinoma: old certainties and new realities. Clin Exp Med (2015) 0.76
Large variations in risk of hepatocellular carcinoma and mortality in treatment naïve hepatitis B patients: systematic review with meta-analyses. PLoS One (2014) 0.76
AFP in chronic hepatitis B virus infection. Hepatology (1989) 0.75
Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma. Medicine (Baltimore) (2017) 0.75
Biomarkers for Hepatocellular Carcinoma. Biomark Cancer (2017) 0.75
Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B. PLoS One (2016) 0.75
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients. Medicine (Baltimore) (2017) 0.75
Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology (1987) 3.65
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology (2000) 3.58
Foreign body aspiration into the lower airway in Chinese adults. Chest (1997) 3.54
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology (1991) 2.75
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology (2001) 2.72
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology (2001) 2.51
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology (2000) 2.26
Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study. Gastroenterology (1979) 1.81
Clear cell carcinoma of liver. An ultrastructural study. Cancer (1983) 1.72
Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. J Hepatol (1990) 1.59
Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study. Gut (1997) 1.47
Necrotizing enterocolitis in neonates with symptomatic congenital heart disease. J Pediatr (1988) 1.46
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology (1992) 1.44
Hepatocarcinogenesis. Trop Gastroenterol (1990) 1.44
Histologic prognostic indicators in hepatocellular carcinoma. Cancer (1979) 1.43
Synergism of chronic alcoholism and hepatitis B infection in liver disease. J Gastroenterol Hepatol (1991) 1.40
A patient with large granular lymphocytosis of unusual phenotype and polymorphic T-cell receptor beta-chain gene rearrangement. Am J Clin Pathol (1990) 1.40
Cholestatic jaundice caused by sequential carbimazole and propylthiouracil treatment for thyrotoxicosis. Hong Kong Med J (2003) 1.38
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol (1996) 1.35
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med (1981) 1.34
Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology (1987) 1.33
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection. Hepatology (2001) 1.32
Nucleic acid-based cross-linking assay for detection and quantification of hepatitis B virus DNA. J Clin Microbiol (1999) 1.29
Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology (1988) 1.28
Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology (2000) 1.27
Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology (1999) 1.25
Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol (1987) 1.24
Treatment of chronic hepatitis B. Lancet Infect Dis (2001) 1.22
Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci (1991) 1.20
Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer (1981) 1.19
Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci (1987) 1.18
Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma. Cancer (2001) 1.16
Health-related quality of life of Southern Chinese with chronic hepatitis B infection. Health Qual Life Outcomes (2009) 1.16
Natural history of chronic hepatitis B virus infection. J Gastroenterol Hepatol (2000) 1.15
Natural history and control of perinatally acquired hepatitis B virus infection. Dig Dis (1992) 1.14
Hepatitis B infection in patients with lymphomas. Hematol Oncol (1991) 1.12
Current seroepidemiology of hepatitis A in Hong Kong. J Med Virol (1991) 1.12
Effect of cimetidine on gonadal function in man. Br J Clin Pharmacol (1982) 1.11
Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut (2001) 1.11
Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. Neurology (1998) 1.09
Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Neurol Sci (1998) 1.09
Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med (1989) 1.09
The role of hepatic arterial embolization in the treatment of spontaneous rupture of hepatocellular carcinoma. Clin Radiol (1998) 1.08
Long-term follow-up in a randomised controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infection. Lancet (1988) 1.08
Inhibition of sulpiride on the cephalic phase of gastric acid and gastrin secretion in duodenal ulcer patients. Scand J Gastroenterol (1976) 1.07
Minimum graft volume for successful adult-to-adult living donor liver transplantation for fulminant hepatic failure. Transplantation (1996) 1.07
Acute cholangitis--predictive factors for emergency ERCP. Aliment Pharmacol Ther (2001) 1.05
Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Hepatology (1997) 1.05
Sequential intravenous/oral antibiotic vs. continuous intravenous antibiotic in the treatment of pyogenic liver abscess. Aliment Pharmacol Ther (2002) 1.04
A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children. Hepatology (1988) 1.04
Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam. Clin Radiol (1993) 1.01
Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy. J Viral Hepat (2007) 0.97
Applicability of living donor liver transplantation to high-urgency patients. Transplantation (1999) 0.97
Factors influencing healing of duodenal ulcer. Control of nocturnal secretion by H2 blockade and characteristics of patients who failed to heal. Dig Dis Sci (1985) 0.97
Seroepidemiological survey of hepatitis E in Hong Kong by recombinant-based enzyme immunoassays. Lancet (1992) 0.96
Precore sequence variation in Chinese isolates of hepatitis B virus. J Infect Dis (1992) 0.96
Hepatocellular carcinoma expressing both hepatocellular and biliary markers also expresses cytokeratin 14, a marker of bipotential progenitor cells. J Hepatol (1999) 0.95
Human stomach alcohol and aldehyde dehydrogenases: comparison of expression pattern and activities in alimentary tract. Gastroenterology (1997) 0.94
Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut (1996) 0.93
Interferon therapy of chronic hepatitis B virus infection in Chinese. J Hepatol (1986) 0.92
Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children. Hepatology (1999) 0.92
Factors determining the development of hepatocellular carcinoma in hepatitis B surface antigen carriers. A comparison between families with clusters and solitary cases. Cancer (1988) 0.91
Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance. Cancer (1987) 0.89
Evidence for intrafamilial transmission of hepatitis B virus from sequence analysis of mutant HBV DNAs in two Chinese families. Lancet (1990) 0.89
Five-year experience with the development of a liver transplant program in Hong Kong. Transplant Proc (1998) 0.89
Transesophageal echocardiography in the detection of inferior vena cava and cardiac metastasis in hepatocellular carcinoma. Clin Cardiol (1996) 0.89
Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg (2001) 0.89
Wilson's disease: 35 years' experience. Q J Med (1990) 0.88
Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases. Hepatology (1991) 0.88
Hepatitis C viremia in patients with hepatitis C virus infection. Hepatology (1992) 0.88
An oligonucleotide probe for the detection of hepatitis B virus DNA in serum. J Virol Methods (1987) 0.88
Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study. J Viral Hepat (2011) 0.87
Treatment of chronic hepatitis B with interferon: experience in Asian patients. Semin Liver Dis (1989) 0.87
Treatment of fibrosing cholestatic hepatitis with lamivudine. Gastroenterology (1998) 0.87
Prevalence and characteristics of familial hepatocellular carcinoma caused by chronic hepatitis B infection in Hong Kong. Aliment Pharmacol Ther (2004) 0.86
Relationship between intrahepatic expression of hepatitis B viral antigens and histology in Chinese patients with chronic hepatitis B virus infection. Am J Clin Pathol (1993) 0.86
Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology (1995) 0.85
Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong. J Med Virol (1996) 0.85
Efficacy of sucralfate in corpus, prepyloric, and duodenal ulcer-associated gastric ulcers. A double-blind, placebo-controlled study. Am J Med (1985) 0.85
Chronic antral gastritis in duodenal ulcer. Natural history and treatment with prostaglandin E1. Gastroenterology (1986) 0.84
Gastric ulcers with and without associated duodenal ulcer have different pathophysiology. Clin Sci Mol Med (1978) 0.84
Re-evaluation of alpha-interferon treatment of chronic hepatitis B using polymerase chain reaction. J Hepatol (1993) 0.84
The hepatitis C virus genome: a guide to its conserved sequences and candidate epitopes. Virus Res (1993) 0.84
Haemodynamic responses to intravenous cimetidine in subjects with normal lung function and in subjects with chronic airway obstruction. Br J Clin Pharmacol (1981) 0.83
Female children respond to recombinant hepatitis B vaccine with a higher titre than male. J Trop Pediatr (1994) 0.83
Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori. Am J Med (1989) 0.83
Acute pancreatitis complicating acute exacerbation of chronic hepatitis B infection carries a poor prognosis. J Viral Hepat (2001) 0.83
Duodenal ulcer healing by separate reduction of postprandial and nocturnal acid secretions have different pathophysiology. Gut (1985) 0.83
Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera. Hepatology (1991) 0.83
Coeliac disease--objectives of life-long follow-up. Health Bull (Edinb) (1977) 0.83
Wilson's disease in a patient presenting with skeletal abnormalities. Orthopedics (1985) 0.83
Fulminant hepatic failure in nonmetastatic renal cell carcinoma. Dig Dis Sci (1992) 0.82
The diagnostic value of the ratio of serum gamma-glutamyl transpeptidase to alkaline phosphatase in alcoholic liver disease. Scand J Gastroenterol (1982) 0.82
Hypothyroid myopathy-pathological and ultrastructural study. Kaohsiung J Med Sci (2000) 0.82